Compare XCUR & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XCUR | MRM |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 7.6M |
| IPO Year | 2017 | 2020 |
| Metric | XCUR | MRM |
|---|---|---|
| Price | $1.28 | $0.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 27.2K | 8.0K |
| Earning Date | 03-25-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $32.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.05 | $0.70 |
| 52 Week High | $9.48 | $2.85 |
| Indicator | XCUR | MRM |
|---|---|---|
| Relative Strength Index (RSI) | 40.77 | 29.55 |
| Support Level | $1.20 | N/A |
| Resistance Level | $1.52 | $1.02 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 2.56 | 10.17 |
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.